BIXT (Bioxytran) E10: $-0.34 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bioxytran E10?

Bioxytran BIXT +11.48% E10 is $-0.34 as of Mar. 2026. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bioxytran's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.34 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 53.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bioxytran was 53.50% per year. The lowest was 24.90% per year. And the median was 43.05% per year.

As of today (2026-07-16), Bioxytran's current stock price is $0.027. Bioxytran's E10 for the quarter that ended in Mar. 2026 was $-0.34. Bioxytran's Shiller PE Ratio of today is .


Bioxytran  (OTCPK:BIXT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bioxytran E10 Related Terms


Bioxytran E10 Historical Data

* Premium members only.

The historical data trend for Bioxytran's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioxytran E10 Chart

Bioxytran Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.70 -4.39 0.00 -1.46 -0.44

Bioxytran Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.43 0.00 0.00 -0.44 -0.34

BIXT vs SPRC, ACUT, DCOY: E10 Comparison

For the Biotechnology subindustry, Bioxytran's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioxytran Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioxytran's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bioxytran's Shiller PE Ratio falls into.



Bioxytran E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bioxytran's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.02/330.2130*330.2130
=-0.020

Current CPI (Mar. 2026) = 330.2130.

Bioxytran Quarterly Data

per share eps CPI Adj_EPS
201606 -0.300 241.018 -0.411
201609 -0.300 241.428 -0.410
201612 0.000 241.432 0.000
201703 -0.900 243.801 -1.219
201706 -0.300 244.955 -0.404
201709 0.046 246.819 0.062
201712 -0.001 246.524 -0.001
201803 0.000 249.554 0.000
201806 0.000 251.989 0.000
201809 -0.001 252.439 -0.001
201812 -0.003 251.233 -0.004
201903 -0.002 254.202 -0.003
201906 -0.002 256.143 -0.003
201909 -0.010 256.759 -0.013
201912 -0.010 256.974 -0.013
202003 -0.010 258.115 -0.013
202006 -0.010 257.797 -0.013
202009 -0.002 260.280 -0.003
202012 -0.010 260.474 -0.013
202103 -0.020 264.877 -0.025
202106 -0.010 271.696 -0.012
202109 -0.004 274.310 -0.005
202112 -0.010 278.802 -0.012
202203 -0.010 287.504 -0.011
202206 -0.010 296.311 -0.011
202209 -0.001 296.808 -0.001
202212 -0.010 296.797 -0.011
202303 -0.010 301.836 -0.011
202306 -0.010 305.109 -0.011
202309 -0.010 307.789 -0.011
202312 0.000 306.746 0.000
202403 0.000 312.332 0.000
202406 0.000 314.175 0.000
202409 0.000 315.301 0.000
202412 -0.010 315.605 -0.010
202503 -0.020 319.799 -0.021
202506 0.000 322.561 0.000
202509 0.000 324.800 0.000
202512 -0.005 324.054 -0.005
202603 -0.020 330.213 -0.020

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.34 mean?
Bioxytran (BIXT) has a E10 of $-0.34 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bioxytran and its competitors.
Is Bioxytran's E10 too high?
Bioxytran's current E10 is $-0.34.
How does Bioxytran's E10 compare to SPRC and ACUT?
Bioxytran's E10 of $-0.34 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bioxytran and its competitors. Bioxytran's current E10 is $-0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioxytran stock overvalued right now?
Bioxytran (BIXT) has a current E10 of $-0.34. The current E10 is $-0.34. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Bioxytran (BIXT), the current E10 is $-0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioxytran Business Description

Address 75 2nd Avenue, Suite 605, Needham, MA, USA, 02494
Bioxytran Inc is a clinical stage pharmaceutical company developing platform technologies in the fields of Glycovirology, Hypoxia and Degenerative Diseases to eliminate viruses and prolong lifespan using carbohydrate drug design. Bioxytran uses Galectin inhibitors to combat the virus, SARS-CoV-2. Glycovirology is a novel glycan-based platform technology. The concept involves using sugar-based drugs to block viruses. The company is developing an inventive platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention.